A Food Effect Study of LY03020 in Healthy Subjects

Phase 1 Active not recruiting 16 enrolled Luye Pharma Group Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This is a randomized, open-label, single-dose, two-period, crossover study to assess the food effect on pharmacokinetics (PK) and safety of LY03020 in healthy subjects.

Timeline

Start: 2025-07-30
Primary completion: 2025-08-27
Completion: 2026-03-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LY03020	Unknown	80 mg	Oral

A Food Effect Study of LY03020 in Healthy Subjects

Summary

Timeline

Drugs

Indications